Articles: palliative-care.
-
Randomized Controlled Trial Comparative Study Clinical Trial
A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone.
The palliative efficacy of strontium-89 chloride has been evaluated in a prospective double-blind crossover study comparing it with stable strontium as placebo in 32 patients with prostate cancer metastatic to bone. Response was assessed 5 weeks after each treatment. 26 patients were evaluable. Complete pain relief was only reported following strontium-89 injection. Statistical comparison between placebo and strontium-89 showed clear evidence of a therapeutic response to strontium-89 compared with only a limited placebo effect (P less than 0.01).
-
Embert Van Tilburg, a specialist in palliative care, shares his insights about the total care of those who are terminally ill due to cancer or AIDS, or of the many elderly who are "dying in the slow lane" in so many of our chronic care institutions.